Cargando…
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
Autores principales: | Marouf, Amira, Cottereau, Anne Segolene, Kanoun, Salim, Deschamps, Paul, Meignan, Michel, Franchi, Patricia, Sibon, David, Antoine, Clara, Gastinne, Thomas, Borel, Cecile, Hammoud, Mohammad, Sicard, Guillaume, Gille, Romane, Cavalieri, Doriane, Stamatoullas, Aspasia, Filliatre-Clement, Lauriane, Lazarovici, Julien, Chauchet, Adrien, Fornecker, Luc-Matthieu, Amorin, Sandy, Rocquet, Mathieu, Raus, Nicole, Burroni, Barbara, Rubio, Marie Therese, Bouscary, Didier, Quittet, Philippe, Casasnovas, Rene Olivier, Brice, Pauline, Ghesquieres, Herve, Tamburini, Jérôme, Deau, Benedicte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244814/ https://www.ncbi.nlm.nih.gov/pubmed/34965701 http://dx.doi.org/10.3324/haematol.2021.279564 |
Ejemplares similares
-
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline
por: Rossi, Cédric, et al.
Publicado: (2022) -
Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT
por: Rossi, Cédric, et al.
Publicado: (2017) -
Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas
por: Revailler, Wendy, et al.
Publicado: (2022) -
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
por: Van Den Neste, Eric, et al.
Publicado: (2018) -
Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30(+) Lymphoma
por: Tudesq, Jean-Jacques, et al.
Publicado: (2017)